MRI-guided focused ultrasound surgery for uterine fibroid treatment: A cost-effectiveness analysis

American Journal of Roentgenology

Volumn 203, Issue 2, 2014, Pages 361-371

  Kong, Chung Y ^a,b   Meng, Lesley ^a   Omer, Zehra B ^a   Swan, J Shannon ^a,b   Srouji, Serene ^b,c   Gazelle, G Scott ^a,b,d   Fennessy, Fiona M ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost effectiveness; Hysterectomy; MRI guided focused ultrasound; Uterine fibroids

Indexed keywords

COST EFFECTIVENESS; HYSTERECTOMY; MRI-GUIDED FOCUSED ULTRASOUND; UTERINE FIBROIDS;

ADULT; COST-BENEFIT ANALYSIS; EFFICIENCY, ORGANIZATIONAL; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; ULTRASONIC THERAPY; UTERINE NEOPLASMS;

EID: 84906483103     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11446     Document Type: Article

References (51)

1. Williams VS, Jones G, Mauskopf J, Spalding J, DuChane J. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health (Larchmt) 2006; 15:818-829 (Pubitemid 46381700)
2. Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J. The economic impact of uterine fibroids in the United States: a summary of published estimates. J Womens Health (Larchmt) 2005; 14:692-703 (Pubitemid 41645631)
3. Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 2006; 195:955-964 (Pubitemid 44415640)
4. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346:671-672
5. Brummer TH, Jalkanen J, Fraser J, et al. FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors. Hum Reprod 2011; 26:1741-1751
6. Hehenkamp WJ, Volkers NA, Bartholomeus W, et al. Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison. Cardiovasc Intervent Radiol 2007; 30:866-875 (Pubitemid 47497872)
7. Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 2004; 191:22-31 (Pubitemid 39077952)
8. Pron G, Bennett J, Common A, et al. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003; 79:120-127 (Pubitemid 36071249)
9. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003; 226:897-905 (Pubitemid 36259169)
10. Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003; 189:48-54 (Pubitemid 36886523)
11. Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology 2007; 243:885-893 (Pubitemid 46799445)
12. American College of Gynecologists. ACOG practice bulletin: alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol 2008; 112:387-400
13. Ringold S. FDA approves ultrasound fibroid therapy. JAMA 2004; 292:2826 (Pubitemid 39628225)
14. Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011; 18:970-976
15. Okada A, Morita Y, Fukunishi H, Takeichi K, Murakami T. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 2009; 34:579-583
16. Trumm CG, Stahl R, Clevert DA, et al. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients. Invest Radiol 2013; 48:359-365
17. O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care 2009; 25:14-25
18. Zowall H, Cairns JA, Brewer C, Lamping DL, Gedroyc WM, Regan L. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG 2008; 115:653-662 (Pubitemid 351357573)
19. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13:89-102 (Pubitemid 23113445)
20. Fennessy FM, Kong CY, Tempany CM, Swan JS. Quality-of-life assessment of fibroid treatment options and outcomes. Radiology 2011; 259:785-792
21. Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005; 106:933-939 (Pubitemid 41532897)
22. Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007; 110:279-287 (Pubitemid 47356651)
23. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998; 51:1271-1276 (Pubitemid 29009527)
24. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276:1253-1258 (Pubitemid 26337709)
25. Goldman L. Cost-effectiveness in a flat world: can ICDs help the United States get rhythm? N Engl J Med 2005; 353:1513-1515 (Pubitemid 41400928)
26. World Health Organization. World Health Statistics 2011. World Health Organization website. www.who.int/whosis/whostat/2011/en/. Published 2011. Accessed April 7, 2014
27. American Medical Association. Current procedural terminology (CPT) 2007. Chicago, IL: American Medical Association, 2007
28. Lave JR, Pashos CL, Anderson GF, et al. Costing medical care: using Medicare administrative data. Med Care 1994; 32(suppl 7): JS77-JS89
29. Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 2004; 230:207-213 (Pubitemid 37549803)
30. Bureau of Labor Statistics. 2013-2014 Occupational Outlook Handbook. U.S. Department of Labor website. www.bls.gov/ooh/. Accessed September 1, 2013
31. Spies JB, Spector A, Roth AR, Baker CM, Mauro L, Murphy-Skrynarz K. Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002; 100:873-880 (Pubitemid 35387453)
32. Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli AM. Uterine artery embolization versus myomectomy: impact on quality of life-results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc Intervent Radiol 2012; 35:530-536
33. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85:22-29 (Pubitemid 43063413)
34. Gorny KR, Woodrum DA, Brown DL, et al. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol 2011; 22:857-864
35. Bouwsma EV, Gorny KR, Hesley GK, Jensen JR, Peterson LG, Stewart EA. Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility. Fertil Steril 2011;
36. Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril 2007; 88:497.e5-497.e7
37. Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93:199-209
38. Ventura SJ, Abma JC, Mosher WD, Henshaw SK. Estimated pregnancy rates for the United States, 1990-2005: an update. Natl Vital Stat Rep 2009; 58:1-14
39. Fennessy FM, Tempany CM. An update on magnetic resonance guided focused ultrasound surgery (MRgFUS) of uterine fibroids. Curr Radiol Rep 2013; 1:136-146
40. Gortázar P, Ravina M, Vázquez JT. Direct quantitative determination of optically active absorbing drugs in human urine by circular dichroism: simultaneous direct determination of beta-lactam antibiotics and proteins. J Pharm Sci 1995; 84:1316-1321
41. Firouznia K, Ghanaati H, Sanaati M, Jalali AH, Shakiba M. Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications? Cardiovasc Intervent Radiol 2008; 31:521-526
42. Kim MD, Lee HS, Lee MH, Kim HJ, Cho JH, Cha SH. Long-term results of symptomatic fibroids treated with uterine artery embolization: in conjunction with MR evaluation. Eur J Radiol 2010; 73:339-344
43. Taran FA, Tempany CM, Regan L, Inbar Y, Revel A, Stewart EA. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol 2009; 34:572-578
44. Zaher S, Gedroyc WM, Regan L. Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2009; 143:98-102
45. Hehenkamp WJ, Volkers NA, Donderwinkel PF, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 2005; 193:1618-1629 (Pubitemid 41540457)
46. Hirst A, Dutton S, Wu O, et al. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids: The HOPEFUL study. Health Technol Assess 2008; 12:1-248 [iii]
47. Mara M, Fucikova Z, Maskova J, Kuzel D, Haakova L. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2006; 126:226-233 (Pubitemid 43786298)
48. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31:73-85
49. Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106:1309-1318 (Pubitemid 41668951)
50. Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis GB. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 1996; 174:654-658 (Pubitemid 26070160)
51. Ravina JH, Beges C, Bouret JM, Ciraru-Vigneron N, Lefevre V, Ferrand S. Pneumoperitoneum related to celioscopy: prevention of vascular wounds (in French). Presse Med 1995; 24:580